Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. J. Jacobs from Edegem, company number BE0700747301, closed financial year 2025 with a result of € 451,855 after tax. For that financial year Dr. J. Jacobs recorded a gross margin of € 641,822 and equity of € 18,600. Compared with financial year 2024, the result moved from € 517,013 to € 451,855. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
€ 18,600
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 451,855
▼ 13% vs 2024
Profit after tax over the fiscal year.
€ 69,796
▼ 61% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 452,783 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 113,108
▲ 54% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,333
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,073
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 632,196 | € 613,139 | € 712,889 | € 641,822 | ▼ 10% |
| Profit after taxes | € 457,390 | € 445,938 | € 517,013 | € 451,855 | ▼ 13% |
| Equity | € 478,437 | € 467,375 | € 19,528 | € 18,600 | ▼ 5% |
| Total debts | € 206,455 | € 138,453 | € 639,125 | € 437,769 | ▼ 32% |
| Cash | € 271,284 | € 144,109 | € 177,961 | € 69,796 | ▼ 61% |
| Retained profit | € 459,837 | € 448,775 | € 928 | € 0 | ▼ 100% |
| Dividend | € 700,000 | € 457,000 | € 964,860 | € 452,783 | ▼ 53% |
| Balance sheet total | € 684,892 | € 605,828 | € 658,653 | € 456,369 | ▼ 31% |
Key figures of Dr. J. Jacobs, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. J. Jacobs?
What happened at Dr. J. Jacobs in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 451,855 (▼ 13% vs 2024). Source: NBB ↗
- Jimmy Jacobs became a director. NBB
- Hebe Vanderbruggen became a director. NBB
- New establishment in Edegem. KBO
- Start of the company according to the CBE. KBO
In short
From € 457,390 profit in 2022 to € 451,855 profit in 2025.
Paid € 601,221 in corporate taxes since 2022.
Best year ever: 2024, with € 517,013 profit.
Paid out € 2.6 million in dividends to the owners in total.
Management
Behind Dr. J. Jacobs are Jimmy Jacobs and Hebe Vanderbruggen. Jimmy Jacobs is also behind ZAZINA.
Directors
According to the 2025 annual accounts
since 2023
Hebe Vanderbruggen
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Wilrijkstraat 201
2650 Edegem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0700.747.301
- VAT number
- BE 0700.747.301
- Registered office
- Wilrijkstraat 201, 2650 Edegem
- Names & denominations
- Dr. J. Jacobs
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 August 2018
- Peppol
- Active · Active since 27 Mar 2025
- Activities · NACE
Activiteiten van medisch specialisten